Cargando…
Imaging for precision medicine: can V‐P SPECT measure mepolizumab response in asthma?
Monoclonal antibody therapies are effective for many but not all people with severe asthma. Precision medicine guides treatment selection using biomarkers to select patients most likely to respond according to their inflammatory endotypes. However, when assessing response to treatment, greater preci...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Ltd
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848709/ https://www.ncbi.nlm.nih.gov/pubmed/33552524 http://dx.doi.org/10.1002/rcr2.717 |